93306

Echocardiography, Transthoracic, Complete (2D, M-mode, Spectral Doppler, Color Doppler)

CPT code 93306 describes a complete transthoracic echocardiogram (TTE), which is a comprehensive, non-invasive ultrasound examination of the heart and great vessels performed from outside the chest wall. This advanced diagnostic procedure utilizes high-frequency sound waves to generate real-time, detailed images of cardiac structures and assess blood flow dynamics. The 'complete' designation signifies a thorough evaluation encompassing several modalities: 2D imaging provides detailed anatomical views of the heart chambers, valves, and surrounding structures; M-mode recording offers precise linear measurements of chamber dimensions and wall thickness, along with an assessment of cardiac motion over time; spectral Doppler echocardiography (including both pulsed-wave and continuous-wave Doppler) measures blood flow velocity and direction across the cardiac valves and within chambers, allowing for the calculation of pressure gradients, estimation of cardiac output, and identification of valvular stenosis or regurgitation; and color flow Doppler echocardiography provides a visual representation of blood flow patterns, aiding in the detection and quantification of valvular regurgitation, shunts, and other flow disturbances. The primary purpose of a complete TTE is to diagnose, evaluate the severity of, and monitor a wide range of cardiovascular conditions, including heart failure, valvular heart disease, cardiomyopathies, pericardial diseases, congenital heart defects, and the presence of intracardiac masses or thrombi. It is an indispensable tool in cardiology for assessing global and regional ventricular function, quantifying ejection fraction, and guiding treatment decisions.

Clinical Indications

  • Evaluation of new or changing cardiac murmurs
  • Assessment of symptoms suggestive of heart failure (e.g., dyspnea, fatigue, edema)
  • Diagnosis and quantification of valvular heart disease (e.g., stenosis, regurgitation)
  • Evaluation of chest pain, particularly when myocardial ischemia or infarction is suspected
  • Assessment of pericardial disease (e.g., pericardial effusion, constrictive pericarditis)
  • Detection and evaluation of congenital heart disease in adults
  • Evaluation of known or suspected cardiomyopathy (e.g., dilated, hypertrophic, restrictive)
  • Assessment of global and regional left ventricular function (ejection fraction, wall motion abnormalities)
  • Detection of cardiac masses, thrombi, or tumors
  • Evaluation of systemic or pulmonary hypertension with suspected cardiac involvement
  • Follow-up of known structural heart disease or cardiac interventions
  • Assessment for sources of embolism (e.g., in stroke workup)
  • Evaluation for infective endocarditis or its complications
  • Assessment of cardiac involvement in systemic diseases

Procedure Steps

  1. Patient positioning: Typically supine or in a left lateral decubitus position to optimize transducer placement and cardiac visualization.
  2. Transducer placement: Acoustic gel applied to the chest, and the transducer is systematically positioned in various locations (e.g., parasternal, apical, subcostal, suprasternal notch).
  3. 2D imaging acquisition: Standard 2D views are obtained, including parasternal long-axis, parasternal short-axis (at multiple levels like aortic valve, mitral valve, papillary muscles, apex), apical 4-chamber, apical 2-chamber, apical long-axis, subcostal 4-chamber, subcostal inferior vena cava (IVC), and suprasternal notch views for the aortic arch.
  4. M-mode recording: M-mode tracings are acquired from specific structures (e.g., left ventricle, aortic valve, mitral valve) for precise dimensional measurements and assessment of wall motion and valve leaflet excursion.
  5. Spectral Doppler: Pulsed-wave (PW) and continuous-wave (CW) Doppler are applied across all four cardiac valves, outflow tracts, and great vessels to measure blood flow velocities, quantify pressure gradients, and assess for valvular stenosis or regurgitation.
  6. Color flow Doppler: Color flow Doppler is used to visualize blood flow patterns within the cardiac chambers and across valves, aiding in the detection and quantification of regurgitant jets, shunts, and areas of turbulent flow.
  7. Measurements and calculations: Comprehensive measurements are taken (e.g., chamber sizes, wall thickness, ejection fraction, stroke volume, valvular orifice areas, pulmonary artery pressures).
  8. Image and video documentation: All acquired images and video clips (cine loops) across all modalities are digitally recorded for review and interpretation.
  9. Comprehensive interpretation and report: A qualified physician (cardiologist) analyzes the acquired data, performs necessary calculations, and generates a detailed report outlining findings, measurements, and a diagnostic impression.

Coding Guidelines

  • CPT code 93306 describes a *complete* transthoracic echocardiogram. To qualify as complete, the study must include comprehensive evaluation of cardiac structure and function utilizing 2D imaging, M-mode, spectral Doppler, and color flow Doppler across all standard views (parasternal, apical, subcostal, suprasternal notch views must be attempted/documented).
  • If fewer than all components or standard views are performed, or if the study is a limited follow-up, CPT code 93308 (Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study) should be used instead.
  • Code 93306 includes both the technical component (performance of the test) and the professional component (interpretation and report). If only the professional component is billed, append modifier 26 (93306-26). If only the technical component is billed, append modifier TC (93306-TC).
  • A complete echocardiogram (93306) typically should not be billed on the same day as a stress echocardiogram (e.g., 93350, 93351) as a resting echo is often considered an integral part of the stress study. Consult payer-specific policies.
  • Only one complete echocardiogram (93306) should be reported per patient per day, unless there are distinct, separately identifiable clinical indications requiring a second *complete* study, which is an uncommon occurrence and requires robust documentation.
  • Medical necessity for a complete study must be clearly documented, including the signs, symptoms, or diagnosed conditions warranting the comprehensive evaluation. Insufficient documentation may lead to down-coding to a limited study (93308) or denial.

Associated ICD-10 Codes